Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2025-06-15Clinical Trial Update: Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients
Teclistamab's expanded access treatment protocol for relapsed or refractory multiple myeloma has been approved for marketing. The sponsor is…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial update for adults with relapsed or refractory multiple myeloma sponsored by Nerviano Medical Sciences. The study stat…
-
CLINICAL_TRIALS withdrawal · 2025-06-13Clinical Trial Update: Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
The IND expanded access program for Janssen's CAR-T therapy for multiple myeloma is no longer available.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients [NA]
ClinicalTrials.gov entry for a study evaluating Sulpegfilgrastim to prevent neutropenia with infection in newly diagnosed non-transplant mul…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating treatment for high-risk newly diagnosed multiple myeloma with minima…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
This clinical trial update describes a study on decision-making, prognosis, quality of life, and satisfaction in adults with relapsed/refrac…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating SAR445514 in relapsed/refractory multiple myeloma and light-chain amyloidosis has been terminated.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease [NA]
A clinical trial is evaluating the Go Wish Game to promote advance care planning in patients with leukemia, multiple myeloma, and other onco…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma [Phase 3]
A Phase 3 trial comparing belantamab mafodotin plus pomalidomide and dexamethasone versus bortezomib plus pomalidomide and dexamethasone in …
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients [NA]
A clinical trial update describes testing a four-drug combination (daratumumab, cabozantinib, pomalidomide, and dexamethasone) for high-risk…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]
A Phase 1 clinical trial evaluating CAR-GPRC5D in relapsed/refractory multiple myeloma or plasma cell leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma [Phase 1]
Phase I study evaluating BCMA-TGF-beta CAR-T cells in relapsed or refractory multiple myeloma; trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting [Phase 2]
This Phase 2 trial evaluating pomalidomide with low-dose dexamethasone, with or without daratumumab, in relapsed or refractory multiple myel…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma [EARLY_Phase 1]
An early-phase clinical trial is evaluating a molecular probe that targets BCMA for the clinical diagnosis of multiple myeloma. The study is…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin (Kepivance) in patients undergoing unrelated donor allogeneic hematopoietic cell transplant…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Doxil/Caelyx BE Study [Phase 1]
Phase 1 bioequivalence study completion for Doxil/Caelyx in ovarian cancer, Kaposi sarcoma, multiple myeloma, and metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluates a quadruplet regimen of ixazomib, lenalidomide, dexamethasone, and daratumumab in newly diagnosed multipl…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment [Phase 3]
A Phase 3 clinical trial is evaluating different drug combinations to treat newly diagnosed multiple myeloma in patients who are not eligibl…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
A protocol to determine the frequency of variants in the GBA and PSAP genes among patients with monoclonal gammopathy of undetermined signif…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers [Phase 1, Phase 2]
A clinical trial update indicates IDP-023 is being studied as a single agent and in combination with antibody therapies in advanced hematolo…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: The Ambient Light Multiple Myeloma Study [NA]
The ambient light study for multiple myeloma is currently recruiting, according to the clinical trials record.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
Early-phase 1 study evaluating CG-105-12 in patients with relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Personalized Autologous Transplant for Multiple Myeloma [Phase 1]
Emory University is conducting a Phase 1 clinical trial evaluating a personalized autologous transplant approach for patients with multiple …
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM) [Phase 1, Phase 2]
This clinical trial update notes the completion of the first-in-human Phase 1/2 study of REGN5459 in adults with relapsed or refractory mult…